Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A new meta-analysis of placebo-controlled trials of calcitonin gene-related peptide (CGRP) antibodies for migraine has shown that the direct biological effects of these treatments beyond the effects of placebo are modest, raising questions about how the ‘true value’ of these and other drugs are assessed.
This Review outlines the advances of molecular treatment of brain metastases from non-small-cell lung cancer, breast cancer and melanoma. Substantial improvements in survival have been achieved in patients with molecular subgroups whose alterations can be targeted with specific molecular compounds.
Neurological soft signs (NSS) are minor motor and sensory changes that accompany the typical psychopathological symptoms and neuropsychological deficits that manifest in the early stages of schizophrenia. A new study provides evidence that NSS in early schizophrenia predict the long-term clinical outcomes of this condition.
Acute respiratory distress syndrome is a common occurrence in COVID-19, an infectious disease caused by the coronavirus SARS-CoV-2. In this article, the authors consider how lung innervation might crosstalk with the immune system to modulate lung function and influence outcomes in COVID-19.
In this Perspective, Pezzini and Padovani critique the evidence for neurological manifestations of COVID-19, including epidemiological, neuropathological and neuroimaging data, and highlight the need for further work to establish whether SARS-CoV-2 is responsible for these symptoms.
Imaging-based assessment is becoming increasingly important in the management of acute stroke, but processing and interpretation of images in clinical practice is challenging. In this Review, Parsons and colleagues explore the potential of artificial intelligence to provide treatment decision support.
In this Review, Tabrizi et al. discuss new insights into the molecular pathogenesis of Huntington disease and outline potential therapeutic strategies, which could include the modulation of DNA repair processes.
The Nigerian Parkinson Disease registry is the first published national Parkinson disease registry in sub-Saharan Africa. Though the clinical data and number of participants are currently limited in comparison with European, North American and Asian equivalents, this registry represents a valuable resource for the field.
A distinct set of CNS diseases are caused by autoantibodies to neuroglial surface proteins, and immunotherapy has limited ability to control these conditions in the long term. In this Review, the authors discuss in detail the B cell biology that underlies these diseases and consider the therapeutic implications.
In this Review, the authors describe the latest developments in the use of machine learning to interrogate neurodegenerative disease-related datasets. They discuss applications of machine learning to diagnosis, prognosis and therapeutic development, and the challenges involved in analysing health-care data.
This Review discusses the advantages and pitfalls of metagenomic next-generation sequencing (mNGS) in patients with encephalitis, meningitis and myelitis. The authors outline data on mNGS test performance, cost and turnaround time and highlight future directions for mNGS technology.